CytoDyn Inc.
CYDY · OTC · USD
$0.2000
−0.0015 −0.74%todayNot financial advice.
- Open
- 0.1980
- Day range
- 0.1980 - 0.2020
- 52-week range
- 0.1829 - 0.3970
- Volume
- 1.98M
- Market cap
- 293.9M
- P/E ratio
- —
- EPS
- -0.03
- Dividend yield
- 0.00%
- Beta
- 1.08
Performance
W
+5.26%
1M
+3.33%
3M
−17.36%
6M
−31.67%
YTD
−33.33%
Y
−22.30%
5Y
−88.64%
All
−75.00%
In the news
Oct 8
CytoDyn to Present Updated Phase 2 CLOVER Study Data for Leronlimab at ESMO Congress 2026
CytoDyn Inc. will share updated Phase 2 CLOVER clinical trial data for leronlimab in treating metastatic colorectal cancer at the ESMO Congress 2026.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/OTC-CYDY" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="CytoDyn Inc. (CYDY) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/OTC-CYDY">CYDY stock price</a> by FreeTheAI Stocks</p>